Zobrazeno 1 - 10
of 30
pro vyhledávání: '"H P, Katz"'
Autor:
Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G. Smaglo, Robert A. Wolff, Shubham Pant, Michael S. Lee, Jason Willis, Michael Overman, Sudheer Doss, Lynn Matrisian, Mark W. Hurd, Rebecca Snyder, Matthew H. G. Katz, Huamin Wang, Anirban Maitra, John Paul Shen, Dan Zhao
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract The relevance of KRAS mutation alleles to clinical outcome remains inconclusive in pancreatic adenocarcinoma (PDAC). We conducted a retrospective study of 803 patients with PDAC (42% with metastatic disease) at MD Anderson Cancer Center. Ove
Externí odkaz:
https://doaj.org/article/07e4c9e5f98d41abaef00dd9155ae1ad
Publikováno v:
Annals of Surgery Open, Vol 5, Iss 2, p e435 (2024)
Externí odkaz:
https://doaj.org/article/f608ada767394e37b4b87f752197a770
Autor:
Christopher Shi, Brian De, Hop S. Tran Cao, Suyu Liu, Marcus A. Florez, Ramez Kouzy, Adam J. Grippin, Matthew H. G. Katz, Ching‐Wei D. Tzeng, Naruhiko Ikoma, Michael P. Kim, Sunyoung Lee, Jason Willis, Sonal S. Noticewala, Bruce D. Minsky, Grace L. Smith, Emma B. Holliday, Cullen M. Taniguchi, Albert C. Koong, Prajnan Das, Ethan B. Ludmir, Eugene J. Koay
Publikováno v:
Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
Abstract Introduction With locally advanced pancreatic cancer (LAPC), uncontrolled local tumor growth frequently leads to mortality. Advancements in radiotherapy (RT) techniques have enabled conformal delivery of escalated‐dose RT (EDR), which may
Externí odkaz:
https://doaj.org/article/0557a6dc1068470ebd1f0ab16f0569c2
Autor:
Craig L Slingluff, Gina R Petroni, Todd Bauer, Nipun Merchant, Osama Rahma, Rawad Elias, Scott Rodig, Matthew H G Katz, Andressa Dias Costa, Brian M Wolpin, Stephanie K Dougan, Chee-Chee Stucky, Kathleen Pfaff, Gauri R Varadhachary, Victoire Cardot-Ruffino, Matthew J Reilley, Patrick Lenehan, Tanios S Bekaii-Saab, Jonathan Andrew Nowak
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)
Background Pancreatic ductal adenocarcinoma (PDAC) is a challenging target for immunotherapy because it has an immunosuppressive tumor microenvironment. Neoadjuvant chemoradiotherapy can increase tumor-infiltrating lymphocyte (TIL) density, which may
Externí odkaz:
https://doaj.org/article/9581129e54704c9a868c55f1b44e76c3
Autor:
Maria E. Monberg, Heather Geiger, Jaewon J. Lee, Roshan Sharma, Alexander Semaan, Vincent Bernard, Justin Wong, Fang Wang, Shaoheng Liang, Daniel B. Swartzlander, Bret M. Stephens, Matthew H. G. Katz, Ken Chen, Nicolas Robine, Paola A. Guerrero, Anirban Maitra
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-16 (2022)
It is unclear if the molecular profiles of pancreatic ductal adenocarcinoma (PDAC) preclinical models remain stable during propagation. Here, the authors characterise clonal evolution throughout propagation in PDAC cell lines and a patient-derived or
Externí odkaz:
https://doaj.org/article/13da03377a014aa3a9ce29578b70d151
Autor:
Julia E. Douglas, Suyu Liu, Junsheng Ma, Robert A. Wolff, Shubham Pant, Anirban Maitra, Eric P. Tamm, Priya Bhosale, Matthew H. G. Katz, Gauri R. Varadhachary, Eugene J. Koay
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Personalized and effective treatments for pancreatic ductal adenocarcinoma (PDAC) continue to remain elusive. Novel clinical trial designs that enable continual and rapid evaluation of novel therapeutics are needed. Here, we descr
Externí odkaz:
https://doaj.org/article/cc2751429ea2496480efe5dbba5ad079
Autor:
An Ngo‐Huang, Holly M. Holmes, Jude K. A. des Bordes, Nathan H. Parker, David Fogelman, Maria Q. B. Petzel, Juhee Song, Eduardo Bruera, Matthew H. G. Katz
Publikováno v:
Cancer Medicine, Vol 8, Iss 6, Pp 2867-2876 (2019)
Abstract Background Frailty is a syndrome characterized by weakness, slow gait, weight loss, exhaustion, and low activity. We sought to determine whether frailty was associated with age or stage in newly diagnosed patients with pancreatic ductal aden
Externí odkaz:
https://doaj.org/article/605ad2b9b8284ad2aa1d542c13187208
Autor:
An Ngo-Huang DO, Aliea Herbert MD, Rhodora C. Fontillas DPT, Nathan H. Parker PhD, Roan Asumbrado DPT, Naveen Garg MD, Seyedeh Dibaj PhD, Diane D. Liu MS, Amy H. Ng MD, Ying Guo MD, Ki Y. Shin MD, Matthew H. G. Katz MD, Eduardo Bruera MD
Publikováno v:
Integrative Cancer Therapies, Vol 20 (2021)
Purpose: Sarcopenia and suboptimal performance status are associated with postoperative complications and morbidity in cancer patients. Prehabilitation has emerged as an approach to improve fitness and muscle strength in patients preoperatively. We s
Externí odkaz:
https://doaj.org/article/eb65316f74c049fa85ec8001800f43bb
Autor:
Nathan H. Parker PhD, Jessica Gorzelitz PhD, An Ngo-Huang DO, Bette J. Caan PhD, Laura Prakash MD, Naveen Garg MD, Maria Q. B. Petzel RD, Keri Schadler PhD, Karen Basen-Engquist PhD, Matthew H. G. Katz MD
Publikováno v:
Integrative Cancer Therapies, Vol 20 (2021)
Loss of skeletal muscle and inferior muscle quality are associated with poor prognosis in patients undergoing preoperative treatment for pancreatic cancer, so maintaining skeletal muscle health before surgery may help accelerate patients’ functiona
Externí odkaz:
https://doaj.org/article/96a386f4db0b4f238ddef4c8f61ad32f
Autor:
Jane Thomas, Andreina Colina, Hyunsoo Hwang, Huamin Wang, Matthew H G Katz, Ryan Sun, Jeffrey E Lee, Ching-Wei Tzeng, Robert A Wolff, Kanwal Raghav, Michael J Overman
Publikováno v:
ESMO Open, Vol 5, Iss 6 (2020)
Objective Small bowel adenocarcinoma (SBA) is a rare malignancy with limited evidence regarding outcomes after curative resection of localised disease. We aimed to evaluate presentation and prognostic factors affecting overall survival (OS), relapse-
Externí odkaz:
https://doaj.org/article/333c3df4188b4cfd916512be1883a2d2